PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches.

Caforio, Matteo; de Billy, Emmanuel; De Angelis, Biagio; Iacovelli, Stefano; Quintarelli, Concetta; Paganelli, Valeria; Folgiero, Valentina

Caforio, Matteo; de Billy, Emmanuel; De Angelis, Biagio; Iacovelli, Stefano; Quintarelli, Concetta; Paganelli, Valeria; Folgiero, Valentina.

Afiliação

Caforio M; Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, 00146 Rome, Italy.
de Billy E; Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, 00146 Rome, Italy.
De Angelis B; Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, 00146 Rome, Italy.
Iacovelli S; Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, 00146 Rome, Italy.
Quintarelli C; Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, 00146 Rome, Italy.
Paganelli V; Department of Clinical Medicine and Surgery, University of Naples Federico II, 80125 Naples, Italy.
Folgiero V; Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, 00146 Rome, Italy.

Cancers (Basel) ; 13(16)2021 Aug 11.

Article em En | MEDLINE | ID: mdl-34439194

Palavras-chave

PI3K; PI3K/Akt inhibitors; immunotherapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália